Journal of the National Cancer Institute Advance Access originally published online on September 9, 2008
JNCI Journal of the National Cancer Institute 2008 100(18):1334; doi:10.1093/jnci/djn279
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press.
CORRESPONDENCE |
Re: Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
Affiliation of authors: Department of Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX
Correspondence to: Ashutosh Kumar Pathak, MBBS, PhD, Department of Thoracic/Head and Neck Medical Oncology, Unit 432, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (e-mail: drakpathak@gmail.com).
| The first 10% of the full text of this article appears below. |
The commentary by Lawenda et al. (1) concerning the use of antioxidants during cancer therapy caught our attention because they included our clinical trial (2) among others in their discussion of chemotherapy and antioxidants. In the initial part of the commentary, including the abstract and the introduction, the authors state that "use
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2008 100: 1334-1335.